Hospital Universitario de Salamanca

Salamanca, Castille and LION 37007

0 studies enrolling now · 2 studies all time

What they study most

Acute Lymphoblastic Leukemia, Lymphoma, Non-Hodgkin

Studies at this site

• A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early